Anti-BCA-225 antibody [Cuβ18] (STJ180016)
SPECIFICATIONS
ClonalityMonoclonal
HostMouse
ConjugationUnconjugated
IsotypeIgG1/Kappa
ImmunogenA synthetic peptide
General Information
| Short Description | Mouse monoclonal antibody anti-BCA-225 is suitable for use in Immunohistochemistry research applications. |
| Applications | IHC-P |
| Host | Mouse |
| Reactivity | Human |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Monoclonal |
| Clone ID | Cuβ18 |
| Isotype | IgG1/Kappa |
| Conjugation | Unconjugated |
| Purification | Affinity purified |
| Dilution Range | 1:25β100 |
| Formulation | Tris-HCI buffer containing stabilizing protein (BSA) and <0.1% ProClin |
| Storage Instruction | Store at 2β8Β°C for up to 24 months. Predilute: Ready to use, no reconstitution necessary. Concentrate: Use dilution range and appropriate labβstandardized diluent. Stability after dilution: 7 days at 24Β°C, 3 months at 2β8Β°C, 6months at β20Β°C. |
Target Information
| Immunogen | A synthetic peptide |
| Specificity | Positive control: Breast carcinoma, fallopian tube, or skin |
Additional Info
| Background | Anti-BCA-225 antibody recognizes a human breast carcinoma associated glycoprotein BCA-225 (220-225kD). This protein differs in size and distribution from other breast carcinoma antigens. Unlike other antibodies against breast carcinoma antigens, this antibody does not react with benign or malignant colonic, stomach, prostate, liver, pancreas, thyroid, or parotid tissues. Adenocarcinomas of the lung, ovary and endometrium also stain with this antibody. |
Information sourced from Uniprot.org